Inhibition of 12/15-LOX hyperactivation mitigates cognitive decline in a chronic cerebral hypoperfusion mouse model and in H2O2-induced HT22 cells: therapeutic effects of brozopine

Brozopine (BZP), a novel inhibitor of 12/15-lipoxygenase (12/15-LOX), has previously demonstrated efficacy in mitigating inflammatory and oxidative stress-related injury in cerebral ischaemia models. This study aimed to evaluate the therapeutic potential and underlying mechanisms of BZP in a mouse m...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Xuening Wang, Zhizai Lu, Qiuji Shao, Yi Wang, Zixin Zhang, Zhiyu Wang, Qingran Jia, Jinpeng Zhu, Yiran Song, Lingxu Yuan, Yiming Wang, Shaoyang Xu, Lirou He, Junbiao Chang, Yuan Gao
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Taylor & Francis Group 2025-12-01
Schriftenreihe:	Journal of Enzyme Inhibition and Medicinal Chemistry
Schlagworte:	BZP 12/15-LOX inflammation CCH cognitive decline
Online-Zugang:	https://www.tandfonline.com/doi/10.1080/14756366.2025.2547259
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!